From: Psychotic and schizotypal symptoms in non-psychotic patients with obsessive-compulsive disorder
Y-BOCS pre | Y-BOCS post | BDI pre | BDI post | ||||||
---|---|---|---|---|---|---|---|---|---|
α | Bivariate | Partial | Bivariate | Partial | Bivariate | Partial | Bivariate | Partial | |
Psychotisism pre-treatment | .77 | .25** | .05 | .17 | -.14 | .55** | .50** | .58** | .51** |
Psychotisism post-treatment | .70 | .21* | .32** | .16 | .40** | .36** | .61** | .56** | |
Paranoid ideation pre-treatment | .75 | .23* | .05 | .16 | -.16 | .52** | .48** | .54** | .50** |
Paranoid ideation post-treatment | .75 | .20* | .34** | .19 | .35** | .31** | .59** | .55** | |
Schizotypal signs pre-treatment | .83 | .26** | .06 | .19* | -.15 | .57** | .52** | .58** | .53** |
Schizotypal signs post-treatment | .80 | .22* | .35** | .19 | .41** | .37** | .67** | .63** | |
Sch. nuclear sxs pre-treatment | .41 | .02 | .04 | .04 | .08 | .23** | .23** | .19* | .11 |
Sch. nuclear sxs post-treatment | .04 | .08 | .16 | .11 | .13 | .11 | .20* | .16 | |
BDI pre | .92 | .41** | .14 | .60** | |||||
BDI post | .14 | .40** |